EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Saikosaponin‐b2 Regulates the Proliferation and Apoptosis of Liver Cancer Cells by Targeting the MACC1/c‐Met/Akt Signalling Pathway

Yanxue Zhu, Xingzhi Lv, Ruifang Li iD, Zihan Gao, Chanhao Lei, Lan Wang, Sanqiang Li iD

Advances in Pharmacological and Pharmaceutical Sciences · 2024-01 · 2024 (1)

DOI: 10.1155/2024/2653426 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Pharmacological and Pharmaceutical Sciences, online erschienen am 05.11.2024. Verfasst von Yanxue Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Basic Medicine and Forensic Medicine College, Henan University of Science and Technology, KaiYuan Road 263, Luoyang 47102…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Saikosaponin‐b2 (SS‐b2), an active ingredient derived from the root of Radix Bupleuri, possesses antitumour, anti‐inflammatory, antioxidative and hepatoprotective properties. We investigated the inhibition of tumour proliferation by SS‐b2 and the underlying molecular mechanisms, including the MACC1/p‐c‐Met/p‐Akt pathway expression in HepG2 liver cancer cells and H22 tumour‐bearing mice. Animal experiments showed that SS‐b2 significantly decreased the levels of MACC1, p‐c‐MET and p‐Akt in tumour tissue transplanted with H22 liver cancer cells in mice, while it increased the expression of p‐BAD. The results also revealed a concentration‐dependent suppression of MACC1, p‐c‐Met and p‐Akt expression in the SS‐b2 treatment group compared with the control group. Additionally, the suppression of MACC1 activation by SS‐b2 resulted in a reduction in the viability and proliferation of HepG2 liver cancer cells, and this reduction was comparable to that by doxorubicin (DOX). This suggests that SS‐b2 has significant efficacy in liver cancer, comparable to DOX. Meanwhile, Annexin V‐FITC/PI staining and western blot analysis of cleaved caspase 9 and cleaved caspase 3 demonstrated that SS‐b2 induced apoptosis of HepG2 liver cancer cells. These findings provide experimental evidence suggesting that SS‐b2 is a promising anticancer agent for liver cancer.

Schlagwörter

Stichwörter der Autor:innen

c-Met signallingliver cancermetastasis-associated in colon cancer-1saikosaponin-b2

Autor:innen und Institutionen

  • Department of Pharmacology, Basic Medicine and Forensic Medicine College, Henan University of Science and Technology, KaiYuan Road 263, Luoyang 471023, Henan, China.

ORCID-Profile: Ruifang Li, Sanqiang Li

Förderung

  • Natural Science Foundation of Henan Province

Zitieren

APA

Zhu, Y., Lv, X., Li, R., Gao, Z., Lei, C., Wang, L., & Li, S. (2024). Saikosaponin‐b2 Regulates the Proliferation and Apoptosis of Liver Cancer Cells by Targeting the MACC1/c‐Met/Akt Signalling Pathway. Advances in Pharmacological and Pharmaceutical Sciences, 2024(1). https://doi.org/10.1155/2024/2653426

Vancouver

Zhu Y, Lv X, Li R, Gao Z, Lei C, Wang L, et al. Saikosaponin‐b2 Regulates the Proliferation and Apoptosis of Liver Cancer Cells by Targeting the MACC1/c‐Met/Akt Signalling Pathway. Advances in Pharmacological and Pharmaceutical Sciences. 2024;2024(1). doi:10.1155/2024/2653426

BibTeX
@article{Zhu2024,
  author = {Zhu, Yanxue and Lv, Xingzhi and Li, Ruifang and Gao, Zihan and Lei, Chanhao and Wang, Lan and Li, Sanqiang},
  title = {Saikosaponin‐b2 Regulates the Proliferation and Apoptosis of Liver Cancer Cells by Targeting the MACC1/c‐Met/Akt Signalling Pathway},
  journal = {Advances in Pharmacological and Pharmaceutical Sciences},
  year = {2024},
  volume = {2024},
  number = {1},
  doi = {10.1155/2024/2653426}
}
Kostenlos starten →